Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)
Phase 1
Completed
- Conditions
- Age-Related Macular Degeneration
- First Posted Date
- 2007-05-16
- Last Posted Date
- 2010-03-18
- Lead Sponsor
- Potentia Pharmaceuticals, Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT00473928
- Locations
- 🇺🇸
United States, Arizona, Tucson, Arizona, United States
🇺🇸United States, California, Beverly Hills, California, United States
🇺🇸United States, Florida, Miami, Florida, United States
News
No news found